UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Private Advisor Group LLC

Private Advisor Group LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.8% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 92,882 shares of the healthcare conglomerate’s stock after purchasing an additional 2,528 shares during the period. Private Advisor Group LLC’s holdings in UnitedHealth Group were worth $47,707,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. Signature Estate & Investment Advisors LLC increased its position in UnitedHealth Group by 1.2% in the first quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock worth $820,000 after buying an additional 19 shares during the period. Steph & Co. increased its position in UnitedHealth Group by 1.6% in the first quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock worth $658,000 after buying an additional 20 shares during the period. First City Capital Management Inc. increased its position in UnitedHealth Group by 1.5% in the first quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock worth $688,000 after buying an additional 20 shares during the period. Griffin Asset Management Inc. increased its position in UnitedHealth Group by 0.3% in the first quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock worth $3,414,000 after buying an additional 21 shares during the period. Finally, Physicians Financial Services Inc. increased its holdings in shares of UnitedHealth Group by 5.2% during the first quarter. Physicians Financial Services Inc. now owns 424 shares of the healthcare conglomerate’s stock valued at $216,000 after purchasing an additional 21 shares during the period. 87.25% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.1 %

UNH opened at $517.46 on Friday. The business has a 50-day moving average of $530.11 and a 200-day moving average of $512.45. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The company has a market capitalization of $484.02 billion, a PE ratio of 27.02, a price-to-earnings-growth ratio of 1.61 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. During the same period last year, the business earned $4.70 EPS. The firm’s revenue was up 12.6% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were given a $1.65 dividend. This represents a $6.60 annualized dividend and a yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Argus raised their price target on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday, July 25th. Mizuho raised their target price on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, August 10th. Loop Capital assumed coverage on UnitedHealth Group in a research note on Thursday, June 16th. They set a “buy” rating and a $575.00 target price for the company. BMO Capital Markets raised their target price on UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. Finally, UBS Group raised their target price on UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, July 21st. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $586.40.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total value of $53,059,422.24. Following the sale, the director now directly owns 787,372 shares in the company, valued at approximately $420,669,238.44. The disclosure for this sale can be found here. Insiders have sold a total of 139,051 shares of company stock valued at $74,450,958 in the last three months. Company insiders own 0.40% of the company’s stock.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.